Globus Medical, Inc. (GMED)
Makes surgical implants and robotic guidance systems for spine and orthopedic procedures.
$80.05+0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+52.2%
The outlook
GMED trades at $80.05 with analyst consensus tilted Buy, and the average price target sits roughly 32% above the current level. The stock sits midway through its 52-week range with mixed momentum against its moving averages, while the trailing P/E of 18.7 reflects a moderate valuation relative to the broader bullish analyst lean.
What’s behind the score
Analyst consensusBuy — 1.8 avg of 12 analysts
Price trendMixed vs its moving averages
52-week range57% of the way from its 52-week low to high
Price targetAvg target +32% vs current price
Analyst price target
~12-month · 12 analysts$105.75average target+32.1% vs now
Now $80.05
Low $87.00High $122.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$10.87B
52-wk high
$101.40
52-wk low
$51.79
50-day avg
$79.55
200-day avg
$83.51
Trailing P/E
18.7